An ancillary stack for managing estrogen on an aromatising cycle — an AI primary with a SERM on standby for symptoms.
On an aromatising anabolic cycle, rising estrogen can cause side effects. The standard ancillary is an aromatase inhibitor (anastrozole or exemestane) dosed conservatively to keep estrogen in range rather than crush it — over-suppression brings joint, lipid, libido, and mood problems.
A SERM (tamoxifen) is kept on standby for gyno symptoms specifically. This is pure harm-reduction context for people already on cycle; the recurring theme is that estrogen management is bloodwork-guided and easy to overdo.
| Compound | Role | Dose | Frequency |
|---|---|---|---|
| Anastrozole AI; dose conservatively — don't crush estrogen. | Primary | 0.25-0.5mg EOD or E3D (estrogen management) | Every other day to every 3 days (cycle support); daily (breast cancer) |
| Exemestane Suicidal AI alternative to anastrozole. | Optional | 12.5mg EOD or 25mg E3D (estrogen management) | Every other day to every 3 days (cycle support); daily (breast cancer) |
| Tamoxifen On standby for gyno symptoms specifically. | Optional | 20-40mg oral daily | Once daily |